STAT1 min de lecture
STAT+: Pharmalittle: Sarepta Halts A Duchenne Clinical Trial Over Safety; Why The CVS Health Whistleblower Lawsuit Comes At A Pivotal Moment
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT1 min de lecture
STAT+: Pharmalittle: Senate Bill Would Allow Insulin Makers To Lock In Profits; GSK, Novartis Pledge Funds For Diseases That Mostly Affect The Poor
CVS Caremark will return the Eliquis blood thinner to its formulary, reversing a decision that sparked protests from physicians and patients.
STAT1 min de lecture
STAT+: Pharmalittle: U.K. Inks $1.2 Billion Deal With Moderna For Vaccine Center; Top Biocon Exec Arrested In Bribery Scandal
Enanta Pharmaceuticals filed a lawsuit alleging the Pfizer Covid-19 pill violates a patent for its own Covid drug still in development.
STAT1 min de lecture
STAT+: Pharmalittle: Medicare Could Have Saved Billions If It Paid What Cuban Charges; India’s Drug Controller Accused Of Taking Bribe
The European Commission is investigating whether Vifor Pharma disparaged a rival treatment to its blockbuster drug for iron deficiency.
STAT1 min de lecture
STAT+: Pharmalittle: Merck Is Eyeing Seagen To Beef Up Its Cancer Drug Portfolio; Lawmakers Want GAO To Probe PBMs
Good morning, everyone, and welcome to another working week, although today is actually a holiday on this side of the pond. So consider this something of a bonus feature. If nothing else, this is an opportunity to take a moment to quickly catch up on
STAT1 min de lecture
STAT+: Pharmalittle: FTC Warns Pharma And PBMs About Rebate Schemes; WTO Reaches Covid Vaccine Patent Waiver Deal
The FTC put drugmakers and pharmacy benefit managers on notice that the agency will “ramp up enforcement” of any “illegal bribes and rebate schemes.”
STAT1 min de lecture
STAT+: Pharmalittle: CVS Whistleblower Suit Details Plans To Boost Consumer Drug Costs; Roche Reports Negative Alzheimer’s Trial Results
Starting in 2015, a whistleblower lawsuit alleges CVS Health coordinated an effort to prevent consumers from obtaining low-cost generics.
STAT1 min de lecture
STAT+: Pharmalittle: FDA Panel To Review Covid Shots For Young Children; Shionogi To License Antibiotic To Dozens Of Poor Countries
A FDA advisory panel is scheduled to vote Wednesday whether Covid-19 vaccines should be cleared for use in children as young as 6 months old.
STAT1 min de lecture
STAT+: Pharmalittle: Lawmakers Urge FTC To Probe Blood Thinner Prices; EU Pressures Covid Vaccine Makers To Renegotiate Contracts
EU governments are intensifying pressure on Covid-19 vaccine makers to renegotiate contracts, warning millions of shots that are no longer needed could go to waste.
STAT1 min de lecture
STAT+: Pharmalittle: Canada OKs ALS Drug Still Waiting FDA Approval; WTO Talks On Covid Patent Waiver Are Down To The Wire
At a WTO conference on a response to the pandemic, the issue generating the most debate is a highly controversial proposal to temporarily waive intellectual property rights for vaccines.
STAT1 min de lecture
STAT+: Pharmalittle: FDA Panel Endorses Bluebird Bio Gene Therapy For Rare Disease; GSK Touts RSV Vaccine Trial Results
GSK will apply for approval for its RSV vaccine for older adults, after reporting data showing the shot is the first to work in adults over 60 in a 25,000-volunteer…
STAT1 min de lecture
STAT+: Pharmalittle: FDA Decision On Novavax Covid Shot Could Be Delayed; New Drug Prices Rose 20% Annually In Recent Years
The FDA needs to review changes to the manufacturing process used by Novavax before it can authorize the company’s Covid-19 vaccine.
STAT1 min de lecture
STAT+: Pharmalittle: FDA Panel Endorses Novavax Covid Shot; FTC To Probe Pharmacy Benefit Managers
A FDA expert panel voted overwhelmingly to recommend the agency issue an emergency use authorization for the Novavax Covid-19 vaccine.
STAT1 min de lecture
STAT+: Pharmalittle: FDA Panel Will Scrutinize Novavax Shot For Covid-19; J&J And Emergent Accuse Each Other Of Breach
A FDA advisory panel is set to scrutinize the Novavax Covid-19 vaccine after months of delays and an agency review that found the shots effective but raised a safety concern.
STAT1 min de lecture
STAT+: Pharmalittle: Cancer Drug Trial Yields Remission In Every Patient; Novartis Data Hacked By Extortionists
In results called unprecedented, an experimental GSK treatment shrank locally advanced rectal cancer until it was undetectable in all 14 patients in a clinical trial.
STAT1 min de lecture
STAT+: Pharmalittle: Bristol Myers Will Pay $4.1 Billion For Turning Point; Europe Looks To Approve A Smallpox Vaccine For Monkeypox
Bristol Myers Squibb agreed to buy Turning Point Therapeutics to deepen its position in lung-cancer treatments.
STAT1 min de lecture
STAT+: Pharmalittle: ‘Gloomy’ Report Issued On WTO Covid-vaccine Proposal; Biotech ‘Swoon’ Hits Enterprise Value At Many Companies
The biotech malaise has left more than 200 public companies running a business that is worth less than the cash they have in the bank.
STAT1 min de lecture
STAT+: Pharmalittle: Pfizer To Exit Consumer-health Joint Venture With GSK; Access To Obesity Drugs In U.S. Remains ‘Dismal’
Drugmakers and patient advocacy groups have aggressively lobbied for coverage of weight-loss drugs, but the status quo has not budged.
STAT1 min de lecture
STAT+: Pharmalittle: GSK To Pay Up To $3.3 Billion For Affinivax; Senate Bill Tries To Avoid Another Aduhelm Controversy
Looking to bolster its vaccines business with new technology, GSK is buying Affinivax in a transaction worth up to $3.3 billion.
STAT1 min de lecture
STAT+: Pharmalittle: Will Widening Access To A Covid Pill Cause Resistance? Monkeypox Vaccine Maker Doesn’t See ‘Panic’
The White House announced steps to make the Pfizer antiviral pill Paxlovid more accessible as it projects Covid-19 infections will continue to spread this summer.
STAT1 min de lecture
STAT+: Pharmalittle: Teva And Allergan Reach $161 Million Opioid Settlement With West Virginia; FDA Lifts Hold On Bharat Covid Shot
Teva and Allergan reached a settlement worth $161.5 million to resolve claims the companies fueled an opioid epidemic in West Virginia.
STAT1 min de lecture
STAT+: Pharmalittle: Pfizer To Sell Medicines And Vaccines To Poor Countries At Low Prices; Germany Orders Vaccine To Combat Monkeypox
Pfizer plans to provide nearly two dozen patent-protected medicines and vaccines at not-for-profit prices to 45 poor countries.
STAT1 min de lecture
STAT+: Pharmalittle: Is The Covid-19 Gold Rush Over For Drugmakers? Monkeypox Attracts Interest From Vaccine Makers
Bavarian Nordic is making more of a smallpox vaccine typically stockpiled for biological warfare, as governments seek to offer protection against monkeypox.
STAT1 min de lecture
STAT+: Pharmalittle: Pfizer And BioNTech Seek Covid-vaccine Use In Kids Under 5; Pfizer Refunds $290,000 Over Misleading Coupons
Pfizer and BioNTech expect to complete their submission for emergency authorization of their Covid-19 vaccine for children under 5 this week.
STAT1 min de lecture
STAT+: Pharmalittle: Cancer Coalition Aims To Boost Access To Meds In Poor Countries; Moderna’s Vaccine Patent Defense Poses Shield For Others
Covid-19 vaccine makers may find shelter from patent lawsuits under a legal theory Moderna is floating.
STAT1 min de lecture
STAT+: Pharmalittle: Moderna Chair Defends Executive Hiring Process; Analysis Finds Monopoly Tactics Preserve Inhaler Revenues
Moderna chair Noubar Afeyan launched an unflinching defense of the board’s executive hiring process after it was forced to fire its new chief financial officer last week.
STAT1 min de lecture
STAT+: Pharmalittle: Investors Reject Proposals For Covid Vaccine Makers To Share Know-how; CMS Head Says Alzheimer’s Drug Decision Is Rare
CMS head Chiquita Brooks-LaSure says the agency expects to keep covering drugs that the FDA approves through its fast-track accelerated approval pathway, despite its recent decision on Biogen's Aduhelm.
STAT1 min de lecture
STAT+: Pharmalittle: Amgen Faces $7B IRS Back-tax Bill And Fine; McKinsey Exec Apologizes For Opioid Work During Hearing
The top executive at McKinsey appeared for the first time before Congress to answer for the consulting firm’s role in fanning the opioid crisis.
STAT1 min de lecture
STAT+: Pharmalittle: J&J Sues Wholesalers And A Pharmacy Over Fake HIV Meds; Rite Aid To Pay $123 Million To Humana For Inflating Drug Prices
Rite Aid was ordered to pay nearly $123 million to Humana for allegedly seeking inflated reimbursements for prescription drugs.
STAT1 min de lecture
STAT+: Pharmalittle: White House Announces Covid-pill Push; ‘Right-to-try’ Think Tank Is Back With A New Law
The Biden administration announced a series of initiatives aimed at increasing the use of antiviral pills to treat Covid-19, with a focus on Pfizer's Paxlovid.
... Ou découvrez quelque chose de nouveau